- Investing Ideas
- U.S. Top Growth Stocks
U.S. Top Growth Stocks
Results
113
113 companies
Mobilicom
Market Cap: US$61.8m
Provides software and cybersecurity solutions and hardware products that are embedded into small-sized drones, unmanned aerial vehicles (SUAVs), and robotic systems in Israel, the United States, Canada, and internationally.
MOB
US$4.89
7D
-13.6%
1Y
n/a
Live Oak Bancshares
Market Cap: US$1.9b
Operates as the bank holding company for Live Oak Banking Company that provides various banking products and services in the United States.
LOB
US$41.40
7D
7.3%
1Y
38.9%
Cheetah Mobile
Market Cap: US$93.4m
Provides internet services, artificial intelligence (AI), and other services in the People’s Republic of China, Hong Kong, Japan, and internationally.
CMCM
US$3.01
7D
-13.3%
1Y
-35.7%
TriSalus Life Sciences
Market Cap: US$290.5m
Engages in the research, development, and commercialization of drug delivery technology platform and immuno-oncology therapeutics to improve outcomes for patients with difficult-to-treat liver and pancreatic cancers in the United States.
TLSI
US$4.73
7D
12.6%
1Y
-13.2%
Pinnacle Financial Partners
Market Cap: US$15.2b
Operates as the bank holding company for Pinnacle Bank that provides various banking products and services to individuals, businesses, and professional entities in the United States.
PNFP
US$101.04
7D
4.7%
1Y
-8.5%
FinWise Bancorp
Market Cap: US$211.3m
Operates as the bank holding company for FinWise Bank that provides various banking products and services to individual and corporate customers in Utah.
FINW
US$15.42
7D
9.7%
1Y
2.7%
Aytu BioPharma
Market Cap: US$23.3m
A pharmaceutical company, focuses on commercializing novel therapeutics in the United States and internationally.
AYTU
US$2.17
7D
-3.6%
1Y
-0.5%
Rezolute
Market Cap: US$526.5m
A late-stage rare disease company, focused on improving outcomes for individuals with hypoglycemia caused by hyperinsulinism in the United States.
RZLT
US$5.04
7D
-2.1%
1Y
13.0%
Praxis Precision Medicines
Market Cap: US$9.1b
A clinical-stage biopharmaceutical company, engages in the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalance in the United States.
PRAX
US$327.79
7D
8.0%
1Y
679.5%
Citius Pharmaceuticals
Market Cap: US$14.8m
A biopharmaceutical company, focuses on the development and commercialization of critical care products.
CTXR
US$0.54
7D
-5.2%
1Y
-66.0%
Iovance Biotherapeutics
Market Cap: US$1.9b
A commercial-stage biopharmaceutical company, develops and commercializes cell therapies using autologous tumor infiltrating lymphocyte for the treatment of metastatic melanoma and other solid tumor cancers in the United States and internationally.
IOVA
US$4.25
7D
4.7%
1Y
147.1%
Journey Medical
Market Cap: US$182.3m
A commercial-stage pharmaceutical company that focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States.
DERM
US$6.62
7D
3.0%
1Y
-7.8%
Mirum Pharmaceuticals
Market Cap: US$7.5b
A biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases.
MIRM
US$123.77
7D
14.8%
1Y
143.2%
ZJK Industrial
Market Cap: US$125.4m
Through its subsidiaries, manufactures and sells precision fasteners, structural parts, and other precision metal parts products in the People’s Republic of China, Taiwan, Singapore, the United States, and internationally.
ZJK
US$1.95
7D
-5.8%
1Y
-49.9%
MNTN
Market Cap: US$711.1m
Operates a technology platform that brings performance marketing to Connected TV.
MNTN
US$9.62
7D
20.6%
1Y
-56.0%
Inter & Co
Market Cap: US$2.4b
Through its subsidiaries, engages in the banking and spending, investments, insurance brokerage, and inter shop businesses in Brazil and the United States.
INTR
US$5.44
7D
0.9%
1Y
-26.8%
Webull
Market Cap: US$3.7b
Operates as a digital investment platform.
BULL
US$6.82
7D
-0.6%
1Y
-43.0%
Esquire Financial Holdings
Market Cap: US$970.6m
Operates as the bank holding company for Esquire Bank, National Association that provides commercial banking products and services to legal and small businesses, and commercial and retail customers in the United States.
ESQ
US$118.47
7D
3.9%
1Y
25.2%
Gyre Therapeutics
Market Cap: US$574.7m
A pharmaceutical company, engages in the development and commercialization of small-molecule, anti-inflammatory, and anti-fibrotic drugs targeting organ fibrosis.
GYRE
US$6.29
7D
2.6%
1Y
-14.4%
Fennec Pharmaceuticals
Market Cap: US$382.8m
Operates as a commercial stage biopharmaceutical company in the United States.
FENC
US$11.02
7D
15.6%
1Y
32.8%
Coastal Financial
Market Cap: US$1.2b
Operates as the bank holding company for Coastal Community Bank that provides various banking products and services to consumers and small and medium-sized businesses in the Puget Sound region in Washington.
CCB
US$77.25
7D
7.2%
1Y
-20.3%
Symbotic
Market Cap: US$24.9b
An automation technology company, develops technologies to enhance operating efficiencies in modern warehouses.
SYM
US$41.24
7D
2.6%
1Y
6.2%
HawkEye 360
Market Cap: US$2.1b
Operates as a space-enabled defense technology company in the United States.
HAWK
US$21.25
7D
-4.6%
1Y
n/a
Caledonia Mining
Market Cap: US$382.6m
Engages in the exploration, development, and production of gold in Zimbabwe.
CMCL
US$19.81
7D
-3.9%
1Y
2.5%
USA Rare Earth
Market Cap: US$4.7b
Engages in mining, processing, and supplying rare earths and other critical minerals in the United States, Europe, and Asia.
USAR
US$20.47
7D
-15.1%
1Y
86.9%
Legend Biotech
Market Cap: US$5.5b
Through its subsidiaries, operates as a biopharmaceutical company that discovers, develops, manufactures, and commercializes novel cell therapies for oncology and other indications in the United States, China, and Europe.
LEGN
US$28.69
7D
-2.2%
1Y
-19.2%
NeurAxis
Market Cap: US$90.0m
A medical technology company, focuses on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults in the United States.
NRXS
US$7.27
7D
1.5%
1Y
200.4%
Prothena
Market Cap: US$524.6m
A late-stage clinical biotechnology company, focuses on discovery and development of novel therapies to treat diseases caused by protein dysregulation.
PRTA
US$10.02
7D
9.5%
1Y
65.1%
Everpure
Market Cap: US$23.0b
Provides data storage and management technologies, products, and services in the United States and internationally.
P
US$69.16
7D
-10.2%
1Y
20.1%
BioHarvest Sciences
Market Cap: US$62.8m
Operates as a biotechnology company in Israel and the United States.
BHST
US$2.77
7D
-9.2%
1Y
-58.8%
Alpha Cognition
Market Cap: US$141.5m
A biopharmaceutical company, engages in the development of treatments for patients suffering from neurodegenerative diseases in the United States and Canada.
ACOG
US$6.50
7D
-3.8%
1Y
-30.3%
Oscar Health
Market Cap: US$9.0b
Operates as a healthcare technology company in the United States.
OSCR
US$29.79
7D
4.4%
1Y
38.9%
Exodus Movement
Market Cap: US$162.4m
Operates as a financial technology for blockchain and digital asset industry in the United States.
EXOD
US$5.41
7D
-11.7%
1Y
-81.2%
Geron
Market Cap: US$846.8m
A commercial-stage biopharmaceutical company, focuses on the development of therapeutics products for oncology.
GERN
US$1.32
7D
-1.5%
1Y
-6.4%
Protagonist Therapeutics
Market Cap: US$7.8b
Operates as a discovery and development company in the United States.
PTGX
US$121.88
7D
6.0%
1Y
120.5%
Hamilton Lane
Market Cap: US$4.4b
A private equity and venture capital firm specializing in early venture, emerging growth, turnaround, middle market, mature, mid-venture, bridge, buyout, distressed/vulture, loan, mezzanine in growth capital companies.
HLNE
US$77.77
7D
-2.2%
1Y
-45.3%